Why the study?
Does catheter ablation improve LVEF in patients with PVC-induced cardiomyopathy, and how do outcomes vary by site of origin?
Population
718 patients with PVC-induced cardiomyopathy (PIC) pooled from 12 studies
Design
Meta-analysis
Key result
Catheter ablation improved LVEF by a mean of 11.0% (95% CI 9.5-12.5; P<.001) in patients with PVC-induced cardiomyopathy, with outcomes favoring RVOT and LVOT origins.
Authors
Loading...
PVC origin influences ablation success in PIC; extends evidence for site-specific risk stratification and procedural planning.
Meta-Analysis (n=718)
Does catheter ablation improve LVEF in patients with PVC-induced cardiomyopathy, and how do outcomes vary by site of origin?
Mean Difference: 11 (95% CI 9.5–12.5)
p-value: p=<.001
Catheter ablation provides substantial and often reversible improvement in LVEF for patients with PVC-induced cardiomyopathy, though success and complication rates are highly dependent on the anatomical site of origin.
Awais et al. (2026) conducted a meta-analysis in PVC-induced cardiomyopathy (n=718). Catheter ablation was evaluated on Change in LV ejection fraction (LVEF) and normalization (≥ 50%) (Mean 11.0%, 95% CI 9.5-12.5, p=<.001). Catheter ablation improved LVEF by a mean of 11.0% (95% CI 9.5-12.5; P<.001) in patients with PVC-induced cardiomyopathy, with outcomes favoring RVOT and LVOT origins.